Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.It has become one of the most controversial words in the world: hydroxychloroquine.For several weeks, the primarily anti-malaria drug has been touted by President Trump and others in the media as a vital aid in treating those suffering from coronavirus, given that there is not yet a Food and Drug Administration-approved treatment.So is there any possible correlation between countries where the drug is routinely administered due to high malaria rates and lower cases of COVID-19? It’s too early to tell, medical professionals say, but it’s part of the investigation process.“If you look [at the] countries where malaria is more prevalent and countries where COVID-19 infections are prevalent, you will find a striking difference. This correlation needs to be explored further as this is not just a mere coincidence,” Dr. David Nazarian, a Beverly Hills-based physician, diplomate at the American Board of Internal Medicine and founder of My Concierge MD, told Fox News.CLICK HERE FOR COMPLETE CORONAVIRUS COVERAGEThe drug initially burgeoned on the scene with an FDA thumbs-up in 1955 and has been used as a proven remedy in the treatment of malaria, rheumatoid arthritis and lupus.After a very small

Continue To Full Article